Approximately 3000 American women are diagnosed with borderline ovarian tumors annually. The most common histologic type of borderline ovarian tumor is the serous type. The article by Bristow et al. focuses on two of the major clinical controversies regarding serous borderline tumors: the significance and classification of the micropapillary pattern and the optimal treatment of recurrence, specifically the role of secondary cytoreductive surgery.
See also pages 675–6 and 791–800.